| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 53.974 | 74.197 | 94.563 | 122.330 | 141.902 | 131.146 | 123.163 | 126.234 | 158.330 | 113.821 |
| Total Income - EUR | 54.316 | 74.767 | 94.591 | 122.331 | 141.904 | 146.334 | 123.165 | 126.246 | 158.342 | 113.825 |
| Total Expenses - EUR | 32.545 | 52.765 | 72.718 | 88.575 | 106.482 | 101.941 | 73.166 | 82.705 | 123.896 | 113.043 |
| Gross Profit/Loss - EUR | 21.771 | 22.003 | 21.873 | 33.756 | 35.422 | 44.394 | 49.998 | 43.541 | 34.446 | 782 |
| Net Profit/Loss - EUR | 20.141 | 21.110 | 14.626 | 32.533 | 34.003 | 43.179 | 49.031 | 42.529 | 33.292 | 228 |
| Employees | 1 | 2 | 2 | 3 | 3 | 2 | 2 | 3 | 4 | 3 |
Check the financial reports for the company - Homeomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 74.665 | 73.750 | 71.306 | 64.400 | 58.819 | 56.992 | 54.209 | 52.015 | 50.802 | 48.020 |
| Current Assets | 39.109 | 39.358 | 39.067 | 44.108 | 44.537 | 38.201 | 47.267 | 33.887 | 30.617 | 12.074 |
| Inventories | 0 | 0 | 390 | 430 | 421 | 413 | 0 | 0 | 0 | 0 |
| Receivables | 38.486 | 39.052 | 38.035 | 41.466 | 39.382 | 35.608 | 35.999 | 31.986 | 28.854 | 43 |
| Cash | 623 | 306 | 642 | 2.213 | 4.733 | 2.180 | 11.268 | 1.901 | 1.763 | 12.030 |
| Shareholders Funds | -7.016 | 14.166 | 22.729 | 32.627 | 42.649 | 50.580 | 75.177 | 83.061 | 77.286 | 59.190 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 120.813 | 99.055 | 87.794 | 75.919 | 60.869 | 45.089 | 26.516 | 3.305 | 5.169 | 4.700 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Homeomed S.r.l.